| HOME >> BIOLOGY >> TECHNOLOGY |
Inventories, net 139.5 152.6
Deferred income taxes 34.8 30.2
Prepaid expenses 30.8 25.4
Other current assets 41.6 37.0
Total current assets 591.6 581.7
Property, plant and equipment, net 223.6 228.2
Goodwill 315.7 350.3
Other intangible assets, net 111.9 122.5
Investments in unconsolidated
affiliates 28.0 34.3
Deferred income taxes 19.7 13.8
Other assets 19.8 14.3
Total assets $1,310.3 $1,345.1
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable and accrued
liabilities $241.6 $225.4
Convertible debt 150.0 150.0
Total current liabilities 391.6 375.4
Long-term debt 62.9 61.7
Other long-term liabilities 78.2 73.0
Stockholders' equity
Common stock 68.9 68.6
Additional contributed capital 695.0 680.6
Retained earnings 566.8 548.6
Accumulated other comprehensive income 17.2 7.5
Common stock in treasury, at cost (570.3) (470.3)
Total stockholders' equity
'/>"/>
| SOURCE Edwards Lifesciences Corporation Copyright©2008 PR Newswire. All rights reserved |